ENDOTAK RELIANCE
Report
- Report Number
- 2124215-2012-14279
- Event Type
- Malfunction
- Date Received
- October 23, 2012
- Date of Event
- July 30, 2012
- Report Date
- December 4, 2012
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- NVY
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
THE LOCAL AREA SALES REPRESENTATIVE WAS CONTACTED FOR ADDITIONAL INFORMATION. AT THIS TIME, NO FURTHER INFORMATION IS AVAILABLE AND RECORDS INDICATE THIS LEAD REMAINS IN SERVICE. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE THIS REPORT WILL BE UPDATED.
THE LEAD WAS RETURNED SEVERED 118 MILLIMETERS (MM) FROM THE TERMINAL PIN IN TWO SEGMENTS. TESTS WERE COMPLETED TO ASSESS LEAD ELECTRICAL PERFORMANCE. MEASUREMENTS THROUGHOUT THESE TESTS WERE WITHIN NORMAL LIMITS. ANALYSIS COULD NOT CONFIRM THE CLINICAL OBSERVATION.
ADDITIONAL INFORMATION WAS RECEIVED INDICATING THIS LEAD WAS EXPLANTED DUE TO A POSSIBLE INFECTION. THE LEAD WAS RETURNED FOR ANALYSIS. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS IMPLANTABLE DEFIBRILLATION LEAD EXHIBITED INCREASE SHOCK IMPEDANCE MEASUREMENTS AND INCREASED PACING THRESHOLD MEASUREMENTS. ADDITIONALLY, R-WAVE MEASUREMENTS DECREASED ALONG WITH PACING IMPEDANCE MEASUREMENTS. A CHEST X-RAY WAS PERFORMED WHICH REVEALED THIS LEAD HAD PULLED BACK AND THE CAN WAS FLIPPED OVER. IT WAS SUSPECTED THE LEAD DISLODGED DUE TO TWIDDLER'S SYNDROME. A LEAD REVISION PROCEDURE WAS SCHEDULED FOR A LATER DATE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ENDOTAK RELIANCE | IMPLANTABLE LEAD | NVY | CPI - DEL CARIBE | 0181 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 52 YR | 0181| E102 |